Heightened competition and looming patent expiries aside, Eli Lilly (LLY) CEO John Lechleitr...

|About: Eli Lilly and Company (LLY)|By:, SA News Editor

Heightened competition and looming patent expiries aside, Eli Lilly (LLY) CEO John Lechleitr says the drugmaker has no plans to merge with a peer. Lechleitr is confident the company's R&D will pay off, though analysts expect Lilly's earnings to fall steadily between now and 2014.